Metformin’s Brain Action Unveiled: Lowering Blood Sugar via RAP1 in the Hypothalamus

Scientists have found that metformin not only acts in the liver and gut but also operates in the brain, where it suppresses the RAP1 protein in a hypothalamic region to activate glucose-lowering neurons, potentially enabling brain-targeted diabetes therapies at very low doses.